Anal cancer with isolated ischial fossa lymph node metastases: A rare entity in the oligometastatic dilemma

J Cancer Res Ther. 2022 Jul-Sep;18(4):1202-1204. doi: 10.4103/jcrt.JCRT_1158_19.

Abstract

Carcinoma of the anal canal is relatively rare cancer with a low propensity for metastasis. A literature review identifies two cases with ischial fossa metastases from anal cancer. The authors present the case of a 62-year-old male with moderately differentiated squamous cell carcinoma of the anal canal who presented with isolated ischial fossa lymph node (LN) confirmed by fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography and pelvic magnetic resonance imaging. The patient was treated with concurrent chemoradiation. Ischial fossa LN was included in the high-dose radiation volume. Posttreatment imaging showed complete clinical response. This case highlights a rare metastatic site from anal cancer treated successfully with primary chemoradiation and shows an example of tailored treatment approach of oligometastatic disease from anal cancer.

Keywords: Anal cancer; chemoradiation; ischial fossa lymph node; metastatic disease; personalized medicine.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Anus Neoplasms* / diagnosis
  • Anus Neoplasms* / pathology
  • Anus Neoplasms* / therapy
  • Carcinoma, Squamous Cell* / diagnostic imaging
  • Carcinoma, Squamous Cell* / therapy
  • Deoxyglucose
  • Humans
  • Lymph Nodes / pathology
  • Lymphatic Metastasis / pathology
  • Male
  • Middle Aged

Substances

  • Deoxyglucose